HomeEthacrynate SodiumEthacrynate Sodium + Lithium

Does Ethacrynate Sodium Interact with Lithium?

Ethacrynate Sodium and Lithium have a major drug interaction according to U.S. FDA drug labeling data. Ethacrynate sodium reduces renal clearance of lithium, increasing risk of lithium toxicity. Concurrent use generally should be avoided. The mechanism involves reduced renal clearance of lithium. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ethacrynate Sodium and Lithium occurs because reduced renal clearance of lithium. Clinically, this means ethacrynate sodium reduces renal clearance of lithium, increasing risk of lithium toxicity. concurrent use generally should be avoided. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Ethacrynate Sodium and your doctor is considering prescribing Lithium (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ethacrynate Sodium(Ethacrynate Sodium)+💊 Lithium(Lithium)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Source
NLP:ethacrynate sodium

What this means in plain English

Ethacrynate sodium reduces renal clearance of lithium, increasing risk of lithium toxicity. Concurrent use generally should be avoided.

What the FDA label says

"Reduced renal clearance of lithium"

📖 Source: NLP:ethacrynate sodium

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Ethacrynate Sodium and Lithium against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.